---

April 27, 2020

Predictmedix Submits Patent Application for Mass Screening for Infectious Diseases

Predictmedix (CSE: PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive to bring news the company has filed a patent for their game-changing technology for mass screening for infectious disease such as COVID-19.…

Read full release →

April 27, 2020

Predictmedix Inc. Files Patent for Mass Screening for Infectious Diseases

TORONTO, April 27, 2020 /CNW/ – Predictmedix Inc. (CSE: PMED) (OTCQB: PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that it has filed Patent Application Number 63012510 – Artificial Intelligence driven rapid screening system…

Read full release →

April 14, 2020

Clinical Experts Join Predictmedix Inc. to Advise Development of Covid-19 Screening Technology

April 14, 2020 (Source) – Predictmedix Inc. (CNSX:PMED) (OTC:PMEDF) (formerly Cultivar Holdings Inc.) (the “Company”) has signed exclusive advisory agreements with clinicians in emergency and pulmonary medicine to aid its efforts in delivering artificial intelligence (“AI”)…

Read full release →

April 08, 2020

CSE Bulletin: Name and Symbol Change – Cultivar Holdings Inc. (CULT)

Toronto, Ontario–(Newsfile Corp. – Le 8 avril/April 2020) – Cultivar Holdings Inc. has announced a name and symbol change to Predictmedix Inc. (PMED). Shares will begin trading under the new name and symbol on April…

Read full release →

March 31, 2020

Cultivar Holdings Inc. Announces US Listing on OTCQB Market Under Symbol CVRHF

TheNewswire – March 31, 2020 – Cultivar Holdings Inc. (CSE:CULT) (CNSX:CULT.CN) (OTC:CVRHF) is pleased to announce that its common shares are now trading on the OTCQB Venture Marketplace (the “OTCQB Venture”), a US trading platform…

Read full release →